Evaluation of the Radiological Dose Delivered to Risky Interventional Cardiology Patients (Optidose)
- Conditions
- X-rays; EffectsChronic Total Occlusion
- Interventions
- Radiation: Gafchromic film
- Registration Number
- NCT05111496
- Lead Sponsor
- Ramsay Générale de Santé
- Brief Summary
The purpose of this study is therefore to study the actual doses of X-rays delivered to the patient's skin during recanalization of a coronary artery in a context of Chronic Total Occlusion
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
- Patient over 18 years-old
- Patient requiring intervention with a predicted risk of exceeding the radiological threshold (Air Kerma> 3Gy): complex coronary dilation, coronary recanalization
- Patient benefiting from a social protection insurance
- Patient having been informed and not objecting to this research
Exclusion Criteria
- Patient refusal to participate in the study
- Patient with known radiosensitivity factors (eg: Lupus)
- Patient having had radiotherapy treatment of the thoracic region.
- Patient whose sum of radiation doses to the skin> 0.5 Gy in the thoracic region in the 3 months preceding inclusion.
- Patient participating in another clinical study
- Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- Pregnant or breastfeeding woman
- Patient hospitalized without consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patient requiring intervention (complex coronary dilation or coronary recanalization) Gafchromic film Patient requiring intervention with a predicted risk of exceeding the radiological threshold (Air Kerma\> 3Gy): complex coronary dilation, coronary recanalization
- Primary Outcome Measures
Name Time Method Dose measured to the patient's skin at the entrance to the X-ray beam 1 month Dose expressed in Gy (Peak skin dose).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital privé La Louvière
🇫🇷Lille, Haut De France, France